Terumo Corporation
TRUMF
Other OTC12.89
USD
- -
- -
ISIN
JP3546800008
Return %
Stock
S&P500
1Y
-19.84
18.21
3Y
-18.62
63.29
5Y
-33.00
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Hikaru Samejima
- Full Time Employees
- 31,185
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 2-44-1, Hatagaya Tokyo TY Japan 151-0072
- IPO Date
- Apr 13, 2011
- Website
- terumo.com
- Similar Companies
- Business
- Terumo Corporation is a Japanese multinational company specializing in medical devices and healthcare products. Its core products and services include the manufacture and sale of cardiovascular systems; blood management systems such as blood transfusion and blood collection devices; vascular intervention devices; infusion systems including infusion pumps and disposables; general hospital supplies; and diagnostic systems. Terumo operates globally, serving hospitals, clinics, and healthcare providers primarily across Asia, Europe, and the Americas. The company was founded in 1921 and is headquartered in Tokyo, Japan. In recent years, Terumo Corporation has focused on strategic expansion and innovation within the medical technology sector. Notably, the company has introduced new product lines in vascular intervention and infusion therapy, enhancing its position in minimally invasive therapies and critical care. Terumo has also engaged in strategic acquisitions and partnerships aimed at broadening its product portfolio and geographic reach, including innovative collaborations to advance technological capabilities in patient monitoring and medical device integration. These moves underscore Terumo’s commitment to advancing healthcare through sustained product development and strategic growth initiatives within the last one to two years. Terumo operates primarily in the healthcare industry sector, targeting hospitals, healthcare systems, and medical professionals worldwide. Its business segments include cardiovascular systems, blood management systems, and general hospital supplies, providing a comprehensive suite of medical products and services designed to improve patient outcomes. The company maintains a strong presence in key global markets, including Japan, the United States, Europe, and emerging markets in Asia, supported by a network of manufacturing facilities and subsidiaries. Overall, Terumo Corporation delivers specialized medical devices and healthcare solutions, with a continued focus on innovation, market expansion, and strategic alliances to maintain its leadership in the global healthcare market. The company’s long history since 1921 and its Tokyo headquarters reflect its established position as a trusted global medical technology provider.